[{"from": "human", "value": "Provide a description of this molecule. [C][C@@H1][Branch2][Ring1][#Branch2][C][N][C][=C][C][=Branch1][Ring2][=N][Ring1][Branch1][C][=C][C][=Branch1][#Branch2][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][#N][Cl][N][C][=Branch1][C][=O][C][=N][N][C][=Branch1][Ring2][=C][Ring1][Branch1][C][Branch1][C][C][O]"}, {"from": "gpt", "value": "The molecule is a formulation containing an androgen receptor (AR) antagonist with potential antineoplastic activity. Darolutamide binds to ARs in target tissues; subsequently, inhibiting androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot translocate to the nucleus. This prevents binding to and transcription of AR-responsive genes that regulate prostate cancer cell proliferation. This ultimately leads to an inhibition of growth in AR-expressing prostate cancer cells."}]